The maintenance of telomeres by telomerase in cancer is therefore likely to be reprogrammable by a defined extracellular environment, probably by a combination of extracellular factors with BMP7 to be an inhibitory cytokine of telomerase-mediated telomere homeostasis. This evidence concerns the gene BMP7 and cancer.